Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Altamira Therapeutics Ltd (NQ: CYTO )

0.2205 +0.0005 (+0.23%)
Streaming Delayed Price Updated: 10:15 AM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,481
Open 0.2200
Bid (Size) 0.2112 (6)
Ask (Size) 0.2205 (2)
Prev. Close 0.2200
Today's Range 0.2183 - 0.2217
52wk Range 0.2100 - 13.52
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RNA Therapies Hold The Power To Transform Treatment For Numerous Ailments, But Delivering These Remains Problematic – Will This Biotech Change That?
Thomas Meyer, CEO of Altamira Therapeutics (NASDAQ: CYTO), was recently a guest on Benzinga’s All-Access. 
Via Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
Via Benzinga

Performance

YTD
-95.76%
-95.76%
1 Month
-37.00%
-37.00%
3 Month
-59.62%
-59.62%
6 Month
-84.14%
-84.14%
1 Year
-95.89%
-95.89%

More News

Read More
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
From Altamira Therapeutics Ltd
Via GlobeNewswire
Earnings Scheduled For September 12, 2023
Via Benzinga
Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
From Altamira Therapeutics Ltd
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Altamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in Scandinavia
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Announces Publication of Positive Results from Clinical Trial with Bentrio in House Dust Mite Allergy in Leading Peer Reviewed Journal
From Altamira Therapeutics Ltd
Via GlobeNewswire
Why Altamira Therapeutics (CYTO) Stock Is Getting Hammered
Via Benzinga
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndrome
Via ACCESSWIRE
Altamira Therapeutics Announces Publication of Peer-Reviewed Article on Peptide-Based RNA Delivery for Extrahepatic Targets
Via ACCESSWIRE
Altamira Therapeutics Reports Positive Top-Line Data from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
Via ACCESSWIRE
Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results
Via ACCESSWIRE
Altamira Therapeutics to Host Fiscal Year 2022 Financial Results and Business Update Call on May 16th 2023
Via ACCESSWIRE
Why Carvana Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.